BiotechTube
c-Lecta

c-Lecta

Leipzig, Germany· Est.
c-lecta.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

c-LEcta is a German biotechnology company and a subsidiary of the Kerry Group, focused on providing enzyme-based solutions for industrial applications in pharma and food. It utilizes its proprietary ENESYZ technology platform for enzyme discovery and strain engineering, offering products like DENARASE for nucleic acid removal in biopharma and Acrylerase for food safety. With over 120 employees and a fully integrated R&D-to-production facility, the company serves as a key innovation and supply partner in regulated markets.

Synthetic BiologyBiologics

Technology Platform

Proprietary ENESYZ platform for enzyme discovery, protein engineering, strain development, and production optimization.

Opportunities

The rapid growth of advanced biotherapeutics (cell/gene therapies) creates sustained demand for high-purity processing enzymes like nucleases and dissociation enzymes.
In food, global trends towards clean-label, natural ingredients and acrylamide reduction drive adoption of enzymatic solutions, where c-LEcta's parent company Kerry has dominant market access.

Risk Factors

Intense competition from large enzyme producers and agile synthetic biology startups could pressure margins and market share.
As a subsidiary, strategic priorities could shift based on the parent company's overall performance, potentially limiting autonomy or investment.
Regulatory hurdles in the pharmaceutical sector and potential quality issues pose reputational and operational risks.

Competitive Landscape

c-LEcta competes with global enzyme giants like Novozymes and International Flavors & Fragrances (IFF, which includes DuPont Nutrition & Biosciences), as well as specialized biocatalysis companies such as Codexis. Its differentiation lies in its integrated platform (ENESYZ), focus on high-value pharma applications, and the commercial and distribution synergy provided by its parent company, Kerry, in the food sector.

More companies in Synthetic Biology →More companies in Germany →